ENTITY
BioDlink International

BioDlink International (1875 HK)

74
Analysis
Health Care • China
Develops, manufactures and markets anti-tumor drugs
more
bullish•CK Hutchison
•25 Jan 2026 06:30

Last Week In Event SPACE: Toyota Industries, Skyworth Group, CK Hutchison, Dongfeng Motor

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
289 Views
Share
•25 Jan 2026 06:15

Asia-Pac M&A Weekly Wrap: Australian Strategic Materials, Qube, Dongfeng Motor, Raksul, IJM Corp

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
309 Views
Share
bearish•Wuxi Biologics
•19 Jan 2026 11:09

StubWorld: WuXi Biologics (2269 HK)'s Double Discounts; Melco (200 HK) Further Out Of Whack

WuXi XDC Cayman (2268 HK)'s Offer for BioDlink International (1875 HK) will add an additional discount layer to WuXi Biologics (2269 HK). Plus...

Logo
551 Views
Share
x